660 skills · sorted by relevance
A hybrid memory system that provides persistent, searchable knowledge management for AI agents (Architecture, Patterns, Decisions).
The English summary is being prepared. Showing the original description.
Build persistent agents on Azure AI Foundry using the Microsoft Agent Framework Python SDK.
The English summary is being prepared. Showing the original description.
Architecture and systems design for building always-on AI agents with episodic memory. Covers the memory hierarchy (core/recall/archival), persistence layers, agent server infrastructure, vector stores, and framework selection. Provides concrete deployment patterns for agents that maintain identity and learn across sessions. Activate on: "always-on agent", "persistent agent architecture", "episodic memory system", "agent memory design", "long-running agent", "stateful agent", "agent that remembers", "MemGPT architecture", "Letta deployment", "/always-on-agent-architecture". NOT for: choosing what data to feed the agent (use always-on-agent-inputs), brainstorming applications (use always-on-agent-applications), safety and privacy concerns (use always-on-agent-safety), general agentic patterns (use agentic-patterns).
The English summary is being prepared. Showing the original description.
Persistent vector memory for Claude Code via LanceDB. Use when: remembering across sessions, storing lessons, recalling past decisions, maintaining context continuity. Tools: memory_store, memory_recall, memory_update, memory_forget, memory_merge.
The English summary is being prepared. Showing the original description.
Use when working in a repository that uses bd or Beads for durable project task tracking, issue dependencies, blocker management, multi-session handoff, or shared work memory. Trigger when the user asks to find ready work, claim or close tasks, create follow-up work, inspect blockers, recover project context, or choose between local planning and persistent project tracking.
The English summary is being prepared. Showing the original description.
Stores a persistent memory or learning with `bd remember` so it survives across sessions. Use when the user invokes `/bdr` or `$bdr`, or asks to remember, note, or persist an insight in a Beads workspace.
The English summary is being prepared. Showing the original description.
Track complex, multi-session work with dependency graphs using bd (beads) issue tracker. Use when work spans multiple sessions, has complex dependencies, or requires persistent context across compaction cycles. For simple single-session linear tasks, TodoWrite remains appropriate.
The English summary is being prepared. Showing the original description.
Implement persistent memory patterns for AI agents using AgentDB. Includes session memory, long-term storage, pattern learning, and context management. Use when building stateful agents, chat systems, or intelligent assistants.
The English summary is being prepared. Showing the original description.
Session-persistent browser automation via Playwright CLI: form filling, screenshots, data extraction, multi-step flows. NOT for autonomous flows (mk:agent-browser) or .spec.ts E2E code (mk:qa-manual).
The English summary is being prepared. Showing the original description.
Weekly-cadence engineering retrospective. Analyzes commit history, work patterns, and code quality metrics with persistent history and trend tracking. Team-aware: breaks down per-person contributions with praise and growth areas. Use when asked to "weekly retro", "what did we ship", or "engineering retrospective". Proactively suggest at the end of a work week or sprint. NOT for per-session or per-task reflection (see mk:memory / Phase 6 Reflect).
The English summary is being prepared. Showing the original description.
Generate and maintain a persistent codebase wiki — LLM-built interlinked markdown knowledge base (Karpathy LLM Wiki pattern)
The English summary is being prepared. Showing the original description.
Save important context to persistent memory for future sessions. PROACTIVELY USE THIS when you detect: - Decisions: "let's go with", "decided to", "chose", "went with" - Learnings: "I learned", "turns out", "TIL", "realized", "discovered" - Errors resolved: "fixed", "the problem was", "solution was" - Client info: names, emails, phone numbers, addresses, invoice amounts - Preferences: "I prefer", "I like", "don't like", "always use" - References: API keys locations, file paths, URLs, credentials - Patterns: "pattern", "convention", "always do", "standard approach" - Important commands run worth remembering Do NOT ask permission - just capture silently when these patterns appear.
The English summary is being prepared. Showing the original description.
This skill determines whether an adolescent or adult patient meets DSM-5 criteria for gender dysphoria (gender incongruence) by evaluating the presence of at least two of six specified criteria over a minimum 6-month duration, accompanied by clinically significant distress or impairment. It is triggered when a clinician queries whether the patient's reported symptoms align with gender dysphoria, such as persistent incongruence between experienced/expressed gender and designated gender.
The English summary is being prepared. Showing the original description.
This skill confirms that medical therapy has normalized cortisol before initiating radiation therapy or radiosurgery for Cushing's syndrome to maintain disease control while awaiting radiation effect. It is triggered when planning pituitary RT/radiosurgery for a patient with persistent or recurrent Cushing's disease after transsphenoidal surgery (TSS) or when medical therapy is being used as a bridge to radiation.
The English summary is being prepared. Showing the original description.
This skill recommends localizing and resecting ectopic ACTH-secreting tumors with node dissection when ectopic ACTH secretion is suspected or confirmed. Clinical triggers include unexplained persistent hypercortisolism after pituitary surgery, elevated ACTH with negative pituitary MRI, or identification of occult ectopic ACTH syndrome (EAS) on biochemical testing.
The English summary is being prepared. Showing the original description.
This skill recommends that all patients with Cushing’s syndrome receive monitoring and adjunctive treatment for cortisol-dependent comorbidities including psychiatric disorders, diabetes, hypertension, hypokalemia, infections, dyslipidemia, osteoporosis, and poor physical fitness. Apply when managing any CS patient to address associated health issues; triggers include confirmed or suspected hypercortisolism, preoperative evaluation, postoperative follow‑up, or persistent hypercortisolism despite treatment.
The English summary is being prepared. Showing the original description.
This skill directs lifelong treatment of cardiovascular risk factors, osteoporosis, and psychiatric symptoms in all patients with Cushing's syndrome until biochemical resolution of hypercortisolism. Use when managing any CS patient for long‑term comorbidity control; triggers include persistent hypertension, dyslipidemia, low bone density, depression, anxiety, or cognitive changes in the setting of known or suspected CS.
The English summary is being prepared. Showing the original description.
Recommends steroidogenesis inhibitors as second-line treatment after transsphenoidal surgery (TSS) in Cushing's disease, as primary therapy for occult or metastatic ectopic ACTH syndrome (EAS), and as adjunctive cortisol reduction in adrenocortical carcinoma. Use when evaluating CS patients post‑TSS, with occult/metastatic EAS, or ACC; triggers include “persistent hypercortisolism after TSS,” “occult EAS,” and “adjunctive for ACC.”
The English summary is being prepared. Showing the original description.
This skill recommends that a multidisciplinary team, including an experienced endocrinologist, incorporates patient values and preferences while providing education about treatment options for Cushing’s syndrome. Use when planning treatment for a CS patient requiring coordinated care; triggers include persistent hypercortisolism after transsphenoidal surgery, consideration of bilateral adrenalectomy, radiotherapy, or medical therapy, and need for shared decision‑making.
The English summary is being prepared. Showing the original description.
Recommends initial surgical resection of the primary lesion(s) causing Cushing's syndrome when surgery is feasible and likely to significantly reduce glucocorticoid excess. Trigger phrases include overt Cushing's syndrome, ACTH-dependent CS, ectopic ACTH secretion, adrenal adenoma, bilateral macronodular adrenal hyperplasia, and persistent hypercortisolism.
The English summary is being prepared. Showing the original description.
Recommends denosumab for adults with refractory or recurrent hypercalcemia of malignancy who have persistent or relapsed hypercalcemia despite intravenous bisphosphonate therapy. Triggered when a clinician observes recurrent hypercalcemia after bisphosphonate treatment or considers next‑line agents for HCM.
The English summary is being prepared. Showing the original description.
Recommends adding intravenous bisphosphonate or denosumab when hypercalcemia due to parathyroid carcinoma is not adequately controlled with a calcimimetic. Consider this adjunct when a clinician notes persistent HCM despite calcimimetic therapy and asks about next-step therapy.
The English summary is being prepared. Showing the original description.
Initiates a 6‑month trial of DHEA replacement in women with primary adrenal insufficiency (PAI) who have persistent low libido, depressive symptoms, or low energy despite otherwise optimized glucocorticoid and mineralocorticoid therapy. If the patient does not report a sustained beneficial effect after 6 months, discontinue DHEA.
The English summary is being prepared. Showing the original description.
Determines whether to add a mineralocorticoid receptor antagonist (e.g., spironolactone or eplerenone) to glucocorticoid therapy in glucocorticoid-remediable aldosteronism when blood pressure fails to normalize with glucocorticoid alone. Triggered by persistent hypertension or inadequate BP control despite optimized glucocorticoid dosing in GRA patients.
The English summary is being prepared. Showing the original description.